Literature DB >> 26113120

Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study.

Anca Florian1, Sabine Rösch2, Michael Bietenbeck1, Markus Engelen1, Jörg Stypmann1, Johannes Waltenberger1, Udo Sechtem2, Ali Yilmaz3.   

Abstract

AIMS: Duchenne (DMD) and Becker (BMD) muscular dystrophies are X-linked recessive disorders associated with both skeletal myopathy and progressive cardiomyopathy in males. Female DMD/BMD carriers (DMDc/BMDc) are mostly free of skeletal muscle symptoms, but they are also prone to cardiomyopathy. The aim of the current study was to characterize the frequency, pattern, and extent of cardiomyopathy in female DMD/BMD carriers (DMDc/BMDc) in comparison to their first-degree male MD relatives. METHODS AND
RESULTS: Thirty-six (age 44 ± 14 years) female MD carriers (20 DMDc and 16 BMDc) constituted the 'MD carrier group' and were prospectively enrolled. All MD carriers underwent a complete CMR study comprising cine- and late gadolinium enhancement (LGE) imaging. In 22 of these women ('female MD carrier comparison group', 7 DMD and 15 BMD), at least one first-degree male relative with a previously established diagnosis of MD underwent the same CMR protocol and was assigned to the 'male MD comparison group' (n = 24, 6 DMD and 18 BMD). In the total MD carrier group, 17 (47%) MD carriers had at least one pathological CMR finding [5 (14%) with a reduced left ventricular ejection fraction (LV-EF) and 16 (44%) with the presence of LGE]. All LGE-positive patients (n = 16) showed non-ischaemic LGE with subepicardial involvement of the LV lateral free wall being the most frequent pattern (13/16, 81%). Compared with BMDc, DMDc demonstrated more frequently a pathological CMR result (65 vs. 19%; P = 0.008)--in spite of being significantly younger (40 ± 11 vs. 50 ± 16 years, P = 0.038). In the male MD comparison group, the same LGE pattern as in female carriers was seen, but with a significantly higher prevalence of cardiac abnormalities compared with their female carrier relatives constituting the female MD comparison group (75 vs. 27%; P = 0.003).
CONCLUSION: Cardiac involvement is a frequent finding in female carriers of DMD, but less frequently observed in carriers of BMD. Those DMDc and BMDc with cardiac involvement demonstrate the same myocardial fibrosis pattern as their male counterparts with overt disease. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiomyopathy; cardiovascular magnetic resonance; late gadolinium enhancement; muscular dystrophy

Mesh:

Substances:

Year:  2015        PMID: 26113120     DOI: 10.1093/ehjci/jev161

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  22 in total

1.  SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients.

Authors:  Eric N Jimenez-Vazquez; Michael Arad; Álvaro Macías; Maria L Vera-Pedrosa; Francisco Miguel Cruz; Lilian K Gutierrez; Ashley J Cuttita; André Monteiro da Rocha; Todd J Herron; Daniela Ponce-Balbuena; Guadalupe Guerrero-Serna; Ofer Binah; Daniel E Michele; José Jalife
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

Review 2.  Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets.

Authors:  Taylor I Schultz; Frank J Raucci; Fadi N Salloum
Journal:  JACC Basic Transl Sci       Date:  2022-03-09

3.  A Parallel Need for Cardiovascular Care for Female Carriers of Duchenne and Becker Muscular Dystrophy.

Authors:  Teresa Wang; Sharlene M Day; Lee R Goldberg; Anjali T Owens; Nosheen Reza
Journal:  J Card Fail       Date:  2022-04-28       Impact factor: 6.592

Review 4.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

5.  DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury.

Authors:  Tatyana A Meyers; Jackie A Heitzman; DeWayne Townsend
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

6.  Muscular and cardiac manifestations in a Duchenne-carrier harboring a dystrophin deletion of exons 12-29.

Authors:  Josef Finsterer; Claudia Stöllberger; Birgit Freudenthaler; Desiree De Simoni; Romana Höftberger; Klaus Wagner
Journal:  Intractable Rare Dis Res       Date:  2018-05

Review 7.  Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Authors:  Karen G Ordovas; Lauren A Baldassarre; Chiara Bucciarelli-Ducci; James Carr; Juliano Lara Fernandes; Vanessa M Ferreira; Luba Frank; Sophie Mavrogeni; Ntobeko Ntusi; Ellen Ostenfeld; Purvi Parwani; Alessia Pepe; Subha V Raman; Hajime Sakuma; Jeanette Schulz-Menger; Lilia M Sierra-Galan; Anne Marie Valente; Monvadi B Srichai
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

8.  Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.

Authors:  Svetlana Becker; Anca Florian; Alexandru Patrascu; Sabine Rösch; Johannes Waltenberger; Udo Sechtem; Matthias Schwab; Elke Schaeffeler; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2016-05-06       Impact factor: 5.364

Review 9.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

10.  Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Int Med Case Rep J       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.